Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dependent Oxytocin Effects on Amygdala in Women
NCT03846739Phase 1Completed
- Sponsor
- University Hospital Bonn
- Start
- Apr 2017
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray (3 arms), sponsored by University Hospital Bonn. Primary endpoints: Neural substrates of emotion processing in the amygdala and Neural substrates of emotion processing in striatal regions. Started Apr 2017; status: completed.
02
Drugs
oxytocin nasal spray
Beyond the preview
Go deeper on NCT03846739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03846739.